 Sildenafil has shown potential effects both on vasodilator mechanisms and as an inhibitor of the NOGMPc Pain activation. The investigators aim at estimating the benefit of sildenafil in term of morbi-mortality in patients with arterial claudication on a multicenter prospective double blind study. 